Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > speaking of facts.onc chat site

<< Previous

Bullboard Posts

Next >>

Comment by CMHarring218431on Jan 13, 2025 12:09pm

94 Views

Post# 36401451

RE:RE:RE:RE:RE:RE:speaking of facts.onc chat site

You left out one option and that is nothing happens.

News around Christmas and we get above average volume with a spike in price. Once that was in the rear view, volume drops as well as the price. Nothing too unusual and obviously indicates nothing. I'm definitely more a believer that if real news is coming, the market usually knows something and both vol/ price clearly indicates such. So, I doubt it would be a complete surprise and we would wake up one day to a trading halt.

Not betting on anything negative just nothing earth shattering, YET. The end of the month after more clinical data, I hope.

<< Previous

Bullboard Posts

Next >>

Anaergia signs $25M biomethane deal in Italy